Low Hexarelin dose and pyridostigmine have additive effect and potentiate to the same extent the GHRH-induced GH response in man
Roberta Giordano
Clinical Endocrinology, 1997
View PDFchevron_right
Arginine and growth hormone-releasing hormone restore the blunted growth hormone-releasing activity of hexarelin in elderly subjects
S. Grottoli
The Journal of Clinical Endocrinology & Metabolism, 1994
View PDFchevron_right
Mechanisms underlying the negative growth hormone (GH) autofeedback on the GH-releasing effect of hexarelin in man
L. Di Vito
Metabolism, 1997
View PDFchevron_right
Hexarelin, a potent GHRP analogue: Interactions with GHRH and clonidine in young and aged dogs
B. Imbimbo
Peptides, 1995
View PDFchevron_right
Pyridostigmine partially restores the GH responsiveness to GHRH in normal aging
Mario Nicolosi
European Journal of Endocrinology, 1990
View PDFchevron_right
Comparisons among old and new provocative tests of GH secretion in 178 normal adults
S. Grottoli
European Journal of Endocrinology, 2000
View PDFchevron_right
Acute administration of hexarelin stimulates GH secretion during day and night in normal men
Marco Cappa
Clinical Endocrinology, 1997
View PDFchevron_right
Acute cardiovascular and hormonal effects of GH and hexarelin, a synthetic GH-releasing peptide, in humans
Maria Rosa Valetto
Journal of Endocrinological Investigation, 1999
View PDFchevron_right
The GH, prolactin, ACTH and cortisol responses to Hexarelin, a synthetic hexapeptide, undergo different age-related variations
L. Di Vito
European Journal of Endocrinology, 1997
View PDFchevron_right
Hexarelin-induced growth hormone response in short stature. Comparison with growth hormone-releasing hormone plus pyridostigmine and arginine plus estrogen
Graziano Grugni
Journal of Endocrinological Investigation, 1999
View PDFchevron_right
Pubblicazione 15 Difference in growth hormone response to growth hormone-releasing hormone
Antonio Giovanni Solimando
View PDFchevron_right
Hexarelin [His-D-2-Methyl-Trp-Ala-Trp-D-Phe-Lys-NH2], a new GH-releasing peptide, is biologically active in male and female rats
B. Imbimbo
Endocrine
View PDFchevron_right
Interaction of the growth hormone releasing peptide hexarelin with somatostatin
H. Koppeschaar
Clinical Endocrinology, 1997
View PDFchevron_right
Low Dose Hexarelin and Growth Hormone (GH)-Releasing Hormone as a Diagnostic Tool for the Diagnosis of GH Deficiency in Adults: Comparison with Insulin-Induced Hypoglycemia Test 1
Chiara Cosci, Maurizio Gasperi
The Journal of Clinical Endocrinology & Metabolism, 1999
View PDFchevron_right
GH-related and extra-endocrine actions of GH secretagogues in aging
V. Locatelli
Neurobiology of Aging, 2002
View PDFchevron_right
Circulating non-22 kDa growth hormone isoforms after a repeated GHRH stimulus in normal subjects
Alejandro Vela
Growth Hormone & IGF Research, 2005
View PDFchevron_right
In VivoSemiquantification of Hypothalamic Growth Hormone-Releasing Hormone (GHRH) Output in Humans: Evidence for Relative GHRH Deficiency in Aging*
Ariel Barkan
The Journal of Clinical Endocrinology and Metabolism, 1999
View PDFchevron_right
Effect of simultaneous administration of GHRH (1–40) and TRH on GH, PRL and TSH secretion in normal man
Roberto Attanasio
Journal of Endocrinological Investigation, 1986
View PDFchevron_right
Effects of GH on the Aging Process in Several Organs: Mechanisms of Action
Jesus Tresguerres
International Journal of Molecular Sciences, 2022
View PDFchevron_right
d-Lys-GHRP-6 does not modify the endocrine response to acylated ghrelin or hexarelin in humans
Flavia Prodam
Neuropeptides, 2007
View PDFchevron_right
Pharmacokinetics and pharmacodynamics of GH: dependence on route and dosage of administration
Christian Strasburger
European Journal of Endocrinology, 2007
View PDFchevron_right
The role of cholinergic tone in modulating the growth hormone response to growth hormone-releasing hormone in normal man
Angela Girelli
Metabolism, 1991
View PDFchevron_right
Growth hormone-releasing activity of hexarelin in humans
L. Benso
European Journal of Clinical Pharmacology, 1994
View PDFchevron_right
Endogenous growth hormone (GH)-releasing hormone is required for GH responses to pharmacological stimuli
Ariel Barkan
Journal of Clinical Investigation, 1996
View PDFchevron_right
The Impact of Cranial Irradiation on GH Responsiveness to GHRH Plus GH-Releasing Peptide-6
Sandra Pekic Djurdjevic
The Journal of Clinical Endocrinology & Metabolism, 2002
View PDFchevron_right
The negative GH auto-feedback in childhood: Effects of rhGH and/or GHRH on the somatotroph response to GHRH or hexarelin, a peptidyl GH secretagogue, in children
Maria Rosa Valetto
Journal of Endocrinological Investigation, 2000
View PDFchevron_right
Lack of effect of hexarelin on TRH-induced TSH response in normal adult man
B. Imbimbo
Journal of Endocrinological Investigation, 1998
View PDFchevron_right
Aging-Related Growth Hormone (GH) Decrease Is a Selective Hypothalamic GH-Releasing Hormone Pulse Amplitude Mediated Phenomenon
Ariel Barkan
The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 2001
View PDFchevron_right
Mechanism of action of Hexarelin. I. Growth hormone-releasing activity in the rat
V. Locatelli
European Journal of Endocrinology, 1996
View PDFchevron_right
Differences in Serum GH Cut-Off Values for Pharmacological Tests of GH Secretion Depend on the Serum GH Method
Mariana Costanzo
Hormone Research in Paediatrics, 2006
View PDFchevron_right
Growth hormone and aging
Jesus Tresguerres
Homo-journal of Comparative Human Biology, 2003
View PDFchevron_right
GH-releasing activity of hexarelin, a new growth hormone releasing peptide, in infant and adult rats
V. Locatelli
Life Sciences, 1994
View PDFchevron_right